ASCIA allergy and anaphylaxis e-training for health professionals (HP) has been developed by the Australasian Society of Clinical Immunology and Allergy (ASCIA) to provide ready access to reliable allergy and anaphylaxis education for health professionals throughout Australia and New Zealand, at no charge.
Development of ASCIA allergy and anaphylaxis e-training HP has included an extensive review process which involved ASCIA members as well as representatives from other medical organisations throughout Australasia.
Course update information - 15 June 2017
The course has been updated to incorporate updated ASCIA Action Plans and changes to EpiPen® and EpiPen®Jr adrenaline (epinephrine) autoinjectors. The devices have not changed, just the instructions on the label, which now include:
- Reduced injection time from 10 to 3 seconds – this is based on research confirming efficacy and delivery of adrenaline through the 3 second delivery.
- Removal of the massage step after the injection – this has been found to reduce the risk of tissue irritation.
EpiPen®s with a 10 second label can continue to be used and should not be replaced unless they have been used, are just about to expire or have expired. All EpiPen®s should now be held in place for 3 seconds, regardless of the instructions on the label. However, if they are held for 10 seconds it will not affect the way that the adrenaline works.
Information Update 7 August 2017
ASCIA allergy and anaphylaxis e-training HP has been developed to provide a single 6 hour learning activity for easier registration and completion for general practitioners. This ASCIA activity is based on the ASCIA anaphylaxis, food allergy, allergic rhinitis and allergen immunotherapy e-training courses.
The ASCIA Allergy and Anaphylaxis Active Learning Module (ALM) was approved by the RACGP QI&CPD Program for 40 (category 1) points in the 2014-2016 triennium.
ASCIA re-applied for this course to be approved for the 2017-2018 triennium. However, as the RACGP requirements have changed, the course in its current format has not been approved for category 1 points, only category 2 points. To be approved for category 1 points the course needs to be significantly amended and ASCIA is in the process of undertaking these amendments.
We apologise for any inconvenience that these changes have caused.
The ASCIA Allergy and Anaphylaxis Active Learning Module has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for up to 6 credits CME for General Practice Educational Programme Stage 2 (GPEP2) and Maintenance of Professional Standards (MOPS) purposes.
- A username and password must be obtained from the ASCIA ALM website registration process to participate in a course.
- This ASCIA ALM comprises four sections which ideally should be completed in order. You can undertake the course at your own pace.
- Sections A-D include evaluations that allow you to monitor your understanding. However the overall course assessment and certificate is only provided after successful completion (a result of 80% or higher) of the final assessment, which comprises questions and case studies addressing all four sections of the course. If this result is not obtained on the first attempt, you may reattempt the assessment after reviewing the course content.
- The Certificate of Completion is a PDF that you can save or print for your own record.